QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing

QIAGEN N.V. ; Frankfurt Prime Standard: QIA) today announced the commercial launch of its QIAGEN Clinical Insight® (QCI™) bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS).

Please to read the entire article.